# China NMPA Drug Inspection - Qinghai Ruicheng Pharmaceutical (Group) Co., Ltd. - Enema for dispersing blood stasis and resolving masses

Source: https://www.keypedia.com/records/china_drug_inspection/qinghai-ruicheng-pharmaceutical-group-co-ltd/91930e1a-6ff7-4169-bfd0-4b34f16be9d7
Source feed: China

> China NMPA drug inspection for Qinghai Ruicheng Pharmaceutical (Group) Co., Ltd. published November 11, 2021. Drug: Enema for dispersing blood stasis and resolving masses. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 2, 2021)
- Company Name: Qinghai Ruicheng Pharmaceutical (Group) Co., Ltd.
- Publication Date: 2021-11-11
- Drug Name: Enema for dispersing blood stasis and resolving masses
- Inspection Finding: Compliant

Company: https://www.keypedia.com/companies/qinghai-ruicheng-pharmaceutical-group-co-ltd/f34f1255-2fe3-48eb-88be-b4670c3a15ae